Moderna is trading at $198.57, up 4.51%, with no clearly verified Moderna-specific announcement explaining the October 5 move.

  • Nasdaq-100 inclusion, effective October 9, remains relevant recent context, but reports tied it to earlier trading—not specifically to this session’s gain.
  • The Nasdaq Composite is up 0.71%, providing a supportive broader-market backdrop, though it does not by itself explain Moderna’s larger move.